Amidst global volatility, trade tensions and talks of dampening growth, is China still an attractive strategy for investors? Do the risks and uncertainties for China based PE funds eventually pay off as compared to other global funds?
The business and cultural fabric in China is vastly different from the rest of the world. What are some of the key considerations that decision makers undertake during expansion or rolling out a new product? Is it better to build or buy a business? What are some of the proven techniques for creating value and driving transformation in a company?
China’s healthcare market has seen a surge in demand driven largely by an ageing demographies and consumers’ want for wellness. Where are some of the key segments in the healthcare value chain to watch?
Cross-border opportunities for China. An ambitious development strategy for the Belt & Road initiative, how has it sought to improve infrastructural connectivity between China and the rest of the world? How can investors position themselves to benefit from these cross-border opportunities? How will this initiative accelerate economic growth across its infrastructure corridors encompassing the different countries? How has AIIB's involvement in the infrastructure network helped in this initiative?